Ars Technica | First genetic engineering therapy approved by the FDA for leukemia Ars Technica For the first time, the Food and Drug Administration has approved a therapy that involves genetically engineering a patient's own cells, the agency announced Wednesday. The therapy, called Kymriah (tisagenlecleucel) by Novartis, will be used to ... US approves genetically engineering blood cells as childhood leukemia treatment |